We tested polymorphisms from the KCNJ9, KCNJ10 and FasL genes (markers that had previously been tested in a number of other genetic disorders, including Multiple Sclerosis (MS) [18]). This evidence concerns the gene KCNJ9 and myeloid sarcoma.